Alternate biomarkers in predicting CD4+ T cell count in HIV patients
Biomarkers in predicting CD4+ T cell count for initiation of antiretroviral therapy in HIV patients in north western Nigeria
Versandkostenfrei!
Versandfertig in 1-2 Wochen
24,99 €
inkl. MwSt.
PAYBACK Punkte
12 °P sammeln!
In many resource-poor countries, most facilities do not have cyflow counter for the performance of CD4+ count analysis required for the initiation of antiretroviral therapy. CD4+ T cell count and viral load monitoring are expensive and unavailable to most human immunodeficiency virus (HIV) infected people in Africa. There is a need to have another marker of HIV infection that is less resource demanding. Studies in human immunodeficiency virus infected adults have demonstrated association of total lymphocyte count (TLC)
In many resource-poor countries, most facilities do not have cyflow counter for the performance of CD4+ count analysis required for the initiation of antiretroviral therapy. CD4+ T cell count and viral load monitoring are expensive and unavailable to most human immunodeficiency virus (HIV) infected people in Africa. There is a need to have another marker of HIV infection that is less resource demanding. Studies in human immunodeficiency virus infected adults have demonstrated association of total lymphocyte count (TLC) <1200 cell/µl and subsequent disease progression or mortality. This study was carried out to determine the relationship of CD4+ T lymphocyte counts with total lymphocyte count (TLC) and immunoglobulin G (IgG) in HIV- positive on highly active antiretroviral therapy (HAART) naive patients attending Specialist Hospital Sokoto northern region, Nigeria. The study population comprised of 100 adult HIV-positive HAART naive patients aged 19-65 years. The CD4+ T cell counts and these alternate biomarkers of study participants were measured. Spearman's rank order correlation was used for statistical analysis.
Andere Kunden interessierten sich für
